Brief: Alpine Immune Sciences Says On Deal Termination Under Specified Conditions Co May Be Required To Pay Vertex Pharmaceuticals Termination Fee Of $173 Million
April 10 (Reuters) - Alpine Immune Sciences Inc
ALPN.O :
* ALPINE IMMUNE SCIENCES: ON DEAL TERMINATION UNDER
SPECIFIED
CONDITIONS CO MAY BE REQUIRED TO PAY VERTEX PHARMACEUTICALS
TERMINATION FEE OF $173 MILLION
Source text for Eikon: ID:n0001193125-24-091936
Further company coverage: ALPN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alpine Immune Sciences
See all newsAlpine Immune Sciences Inc reports results for the quarter ended in January - Earnings Summary
Brief: Alpine Immune Sciences Q1 EPS USD -0.28 Vs. IBES Estimate USD -0.41
Moves: Lazard hires veteran healthcare dealmaker Colocci as vice chairman
U.S. RESEARCH ROUNDUP-Cheesecake Factory, Netflix, Texas Roadhouse
US STOCKS-S&P 500, Nasdaq end sharply higher on soft inflation data, eyes on earnings